Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF
Abstract Tau protein forms self-replicating assemblies (seeds) that may underlie progression of pathology in Alzheimer’s disease (AD) and related tauopathies. Seeding in recombinant protein preparations and brain homogenates has been quantified with “biosensor” cell lines that express tau with a dis...
Main Authors: | Brian D. Hitt, Jaime Vaquer-Alicea, Victor A. Manon, Joshua D. Beaver, Omar M. Kashmer, Jan N. Garcia, Marc I. Diamond |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40478-021-01185-8 |
Similar Items
-
CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
by: Ruocheng Dong, et al.
Published: (2021-01-01) -
18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-09-01) -
CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation
by: Kyu Hwan Shim, et al.
Published: (2020-07-01) -
Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids
by: Aurelien Lathuiliere, et al.
Published: (2021-03-01) -
Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
by: Zhiva Skachokova, et al.
Published: (2019-05-01)